Literature DB >> 32016076

Circulating tumour DNA in early stage colorectal cancer: can blood tell all?

Yat Hang To1, Margaret Lee2,3,4, Peter Gibbs2,3,5, Jeanne Tie1,2,3,5.   

Abstract

Entities:  

Year:  2019        PMID： 32016076      PMCID： PMC6976399          DOI： 10.21037/atm.2019.09.55

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  22 in total

1.  Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.

Authors:  Aimery de Gramont; Eric Van Cutsem; Hans-Joachim Schmoll; Josep Tabernero; Stephen Clarke; Malcolm J Moore; David Cunningham; Thomas H Cartwright; J Randolph Hecht; Fernando Rivera; Seock-Ah Im; György Bodoky; Ramon Salazar; Frédérique Maindrault-Goebel; Einat Shacham-Shmueli; Emilio Bajetta; Martina Makrutzki; Aijing Shang; Thierry André; Paulo M Hoff
Journal:  Lancet Oncol       Date:  2012-11-16       Impact factor: 41.316

2.  Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.

Authors:  Axel Grothey; Alberto F Sobrero; Anthony F Shields; Takayuki Yoshino; James Paul; Julien Taieb; John Souglakos; Qian Shi; Rachel Kerr; Roberto Labianca; Jeffrey A Meyerhardt; Dewi Vernerey; Takeharu Yamanaka; Ioannis Boukovinas; Jeffrey P Meyers; Lindsay A Renfro; Donna Niedzwiecki; Toshiaki Watanabe; Valter Torri; Mark Saunders; Daniel J Sargent; Thierry Andre; Timothy Iveson
Journal:  N Engl J Med       Date:  2018-03-29       Impact factor: 91.245

Review 3.  Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors:  Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

Review 4.  Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq.

Authors:  Scott V Bratman; Aaron M Newman; Ash A Alizadeh; Maximilian Diehn
Journal:  Expert Rev Mol Diagn       Date:  2015-03-16       Impact factor: 5.225

5.  Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Authors:  Thierry Lecomte; Anne Berger; Franck Zinzindohoué; Stéphanie Micard; Bruno Landi; Hélène Blons; Philippe Beaune; Paul-Henri Cugnenc; Pierre Laurent-Puig
Journal:  Int J Cancer       Date:  2002-08-10       Impact factor: 7.396

6.  Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

Authors:  Eric Van Cutsem; Roberto Labianca; György Bodoky; Carlo Barone; Enrique Aranda; Bernard Nordlinger; Claire Topham; Josep Tabernero; Thierry André; Alberto F Sobrero; Enrico Mini; Richard Greil; Francesco Di Costanzo; Laurence Collette; Laura Cisar; Xiaoxi Zhang; David Khayat; Carsten Bokemeyer; Arnaud D Roth; David Cunningham
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

7.  Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Authors:  Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

8.  Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.

Authors:  Jeanne Tie; Yuxuan Wang; Cristian Tomasetti; Lu Li; Simeon Springer; Isaac Kinde; Natalie Silliman; Mark Tacey; Hui-Li Wong; Michael Christie; Suzanne Kosmider; Iain Skinner; Rachel Wong; Malcolm Steel; Ben Tran; Jayesh Desai; Ian Jones; Andrew Haydon; Theresa Hayes; Tim J Price; Robert L Strausberg; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Peter Gibbs
Journal:  Sci Transl Med       Date:  2016-07-06       Impact factor: 17.956

9.  Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients.

Authors:  J Vidal; L Muinelo; A Dalmases; F Jones; D Edelstein; M Iglesias; M Orrillo; A Abalo; C Rodríguez; E Brozos; Y Vidal; S Candamio; F Vázquez; J Ruiz; M Guix; L Visa; V Sikri; J Albanell; B Bellosillo; R López; C Montagut
Journal:  Ann Oncol       Date:  2017-06-01       Impact factor: 32.976

10.  Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.

Authors:  Erin L Symonds; Susanne K Pedersen; David H Murray; Maher Jedi; Susan E Byrne; Philippa Rabbitt; Rohan T Baker; Dawn Bastin; Graeme P Young
Journal:  Clin Epigenetics       Date:  2018-05-16       Impact factor: 6.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.